脱细胞肺细胞外基质水凝胶的开发与表征
December 8th, 2023
该方案阐明了应用于天然牛肺组织的两种不同的脱细胞方法，全面介绍了它们各自的特征。
1 我们的目标是开发器官型肺组织模型。2 因此，我们优化了牛肺组织 4 的脱细胞 3 和肺细胞外基质水凝胶的重建。5 在这项研究中，6 我们试图了解不同脱细胞方法 7 对重构肺水凝胶的生化和机械特性 9 的影响。
10 脱细胞方案11 的主要挑战之一是在重构水凝胶中实现机械稳定性 12,13 这需要了解 14 脱细胞 15 对机械性能的影响。16 这些特性，如刚度和粘弹性，17 对细胞行为有至关重要的影响。18 我们已经建立了方法19 有效地使牛肺脱细胞，20 产生可重复的肺水凝胶 21，与人肺的细胞外基质具有值得注意的相似性 22。
23 因此，在肺的背景下，利用天然肺dECM水凝胶25（natural lung dECM hydrogels）进行疾病建模26（disease modeling）是有很大的希望的24。27 我们设计了组织28 来模拟稳态和疾病条件 29，特别关注细胞基质相互作用。30 因此，我们有兴趣了解器官型细胞外基质的作用 31,32 在独特含量和机械方面 33 对细胞行为的影响。
34 我们目前的研究重点是构建仿生的 35 种患者特异性癌症类器官模型。
View the full transcript and gain access to thousands of scientific videos
概述
本研究聚焦于牛肺组织去细胞化方法的优化，旨在开发一个类器官肺组织模型。研究探讨不同去细胞化技术如何影响重组肺水凝胶的生化和机械性质。
关键研究组成部分
科学领域
- 神经科学
- 生物学
- 组织工程
背景
- 去细胞化对于创建组织模型至关重要。
- 机械稳定性是重组水凝胶的一个挑战。
- 理解机械性质对于细胞行为至关重要。
- 重组水凝胶应模仿人体肺细胞外基质。
研究目的
- 开发可靠的类器官肺组织模型。
- 评估去细胞化方法对肺水凝胶的影响。
- 增强重组水凝胶的机械性质。
使用的方法
- 牛肺组织的去细胞化。
- 水凝胶生化性质的表征。
- 机械性质（如刚度和粘弹性）的评估。
- 肺细胞外基质水凝胶的重组。
主要结果
- 成功的去细胞化产生了可重复的肺水凝胶。
- 水凝胶表现出机械稳定性和相关性质。
- 与人体肺细胞外基质有显著的相似性。
- 关于去细胞化和机械性质之间关系的见解。
结论
- 去细胞化方法显著影响水凝胶的性质。
- 通过优化协议可以实现机械稳定性。
- 本研究有助于肺组织模型的开发。
常见问题
Executive Industry Relevance
Decellularized lung extracellular matrix (ECM) hydrogels offer a reproducible, organotypic platform for modeling lung biology and disease in early discovery and preclinical research. The ability to control and characterize biochemical and mechanical properties enables predictive confidence in cell-matrix interaction studies and supports translational continuity from in vitro models to in vivo relevance. This approach addresses a critical inflection point for portfolio triage by providing a physiologically relevant alternative to commercial ECM products.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of cell-matrix interactions in a native-like lung microenvironment.
- Supports biological de-risking by clarifying the impact of ECM composition and mechanics on cellular behavior.
- Facilitates functional target validation in disease-relevant systems.
Screening & Assay Development
- Provides standardized, reproducible hydrogels for downstream cell-based assays.
- Delivers quantitative mechanical readouts (stiffness, viscoelasticity) to benchmark assay conditions.
- Enables scalable preparation of ECM substrates for high-content screening platforms.
Translational & Preclinical Research
- Aligns in vitro models with human lung ECM properties for improved disease modeling.
- Supports development of patient-specific organoid models for translational biomarker discovery.
- Reduces mechanistic ambiguity in preclinical validation by maintaining native ECM cues.
Pipeline & Workflow Integration
This decellularization and hydrogel characterization workflow bridges early discovery, assay development, and translational research by providing a validated, organotypic ECM platform.
- Discovery Biology: Supports hypothesis testing on ECM-driven cell behavior and pathway modulation.
- Screening: Offers reproducible, quantitative mechanical benchmarks for assay standardization.
- Analytics: Enables measurement of storage and loss moduli, gelation kinetics, and stress relaxation for comparative analysis.
- Translational Research: Facilitates continuity from in vitro to preclinical models by mimicking human lung ECM.
- Enterprise Reuse: Establishes a reusable ECM hydrogel platform adaptable across disease models and screening campaigns.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in cell-matrix studies.
- Operational Value: Delivers standardized, scalable, and reproducible ECM substrates for R&D workflows.
- Strategic Value: Improves go/no-go decision-making and capital efficiency by enabling physiologically relevant model systems.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of disease models and therapeutic hypotheses.
Implementation Considerations
- Requires expertise in tissue decellularization and ECM hydrogel fabrication.
- Needs access to rheometry and histological analysis infrastructure for mechanical and biochemical characterization.
- Demands cross-team standardization of decellularization protocols and hydrogel preparation.
- Adaptation may be necessary for different tissue sources or disease contexts.
- Mechanical properties and ECM composition are sensitive to decellularization method selection.
Biopharma FAQs
Chapters in this video
0:00
Introduction
1:34
Harvesting, Decellularization, and Pepsin Digestion of Bovine Lung Tissues for Decellularized Lung Extracellular Matrix Hydrogel Formation
4:25
Assessment of Gelation Kinetics and Stress‐Relaxation Properties in Decellularized Lung Extracellular Matrix Hydrogels Using Oscillatory Rheology
